Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
Hutton JT, Metman LV, Chase TN, Juncos JL, Koller WC, Pahwa R, LeWitt PA, Samii A, Tsui JK, Calne DB, Waters CH, Calabrese VP, Bennett JP, Barrett R, Morris JL.
Hutton JT, et al. Among authors: pahwa r.
Mov Disord. 2001 May;16(3):459-63. doi: 10.1002/mds.1085.
Mov Disord. 2001.
PMID: 11391739
Clinical Trial.